Article: ACCOLATE -zafirlukast- Approved by FDA for Children with Asthma Seven Years of Age and Older.

WILMINGTON, Del.--(BUSINESS WIRE)--Sept. 20, 1999--

New, safe treatment option now available to help control

asthma in children

A new pediatric formulation of the popular asthma medication, ACCOLATE(R) (zafirlukast), has received approval from the U.S. Food and Drug Administration (FDA) for use in patients as young as seven years of age.

The product will be available in a 10- milligram, nonflavored minitablet specifically designed for children. Recommended dosing is one 10-mg minitablet twice daily, even during symptom free periods.

Since 1996, ACCOLATE has helped control symptoms for asthma sufferers 12 years of age and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!